Numab
Tiago Silva is a Research Associate II at Numab Therapeutics AG, with prior experience as an Associate Scientist at Agenus and a Research Associate at FairJourney Biologics, where expertise was gained in monoclonal antibody solutions, from discovery to engineering. Tiago's academic background includes a Master's degree in Oncology and Cancer Biology from the Institute of Biomedical Sciences Abel Salazar of the University of Porto and a Bachelor's degree in Biochemistry from the Faculty of Sciences of the University of Porto. During the Master thesis project at IPATIMUP, research focused on the role of Syndecan-4 in gastric cancer cell biology within the Glycobiology in Cancer Group.
Previous companies
This person is not in any offices
Numab
Numab Therapeutics is an oncology-focused biopharmaceutical company based in the Zurich-area, Switzerland. At Numab, they are writing the next chapter in cancer immunotherapy by creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies.